MDXGMIMEDX GROUP, INC.
Surgical & Medical Instruments & Apparatus
- Revenue
- $419M
- 20% YoY
- Operating margin
- 15.3%
- 9.6% YoY
- EBITDA
- $79M
- 21% YoY
- Market cap
- —
- Employees
- —
- Net debt / EBITDA
- -1.3×
- −$103M net debt
- AI in 10-K
- —
Red flags 0 of 9
- TSR below peersClear—3+ of last 5 years
- High CEO pay despite TSRClear—Median CEO pay ≥ $15M and TSR flag
- Active 13DClear0 filingsActive-intent 13D in 18 months
- Net insider sellingClear$0 netNet sales over $10M in 12 months
- Earnings not backed by cashClear152% of net incomeCash flow under 80% of net income
- Dilutive SBCClear4% of revenueOver 10% of revenue
- Payouts exceed cash flowClear0% of cash flowBuybacks + dividends over cash flow
- Goodwill-heavyClear7% of assetsOver 40% of assets
- Shareholder dissentClear—Any vote under 80% support
Financials
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | YoY |
|---|---|---|---|---|---|---|
| Revenue | $242M | $268M | $321M | $349M | $419M | 20% |
| Operating income | −$7M | −$15M | $37M | $59M | $64M | 8.5% |
| Net income | −$10M | −$30M | $58M | $42M | $49M | 15% |
| Operating cash flow | −$2M | −$18M | $27M | $66M | $74M | 12% |
| Capex | $3M | $2M | $2M | — | — | |
| Stock-based comp | $14M | $11M | $17M | $17M | $16M | 3.2% |
| Buybacks | $0 | $0 | $10M | $0 | $0 |
Deal filings
None.
13D filers
None on file.
Insider trading
- Open-market buys, 12 mo
- $0 · 0
- Open-market sells, 12 mo
- $432K · 1
- Net
- −$432K
Pay vs performance
| Year | CEO total comp | Comp actually paid | TSR (indexed) | Peer TSR |
|---|---|---|---|---|
| FY2025 | — | — | 75 | — |
| FY2024 | — | — | 106 | — |
| FY2023 | — | — | 97 | — |
| FY2022 | — | — | 31 | — |
| FY2021 | — | — | 67 | — |